Trinity Appoints Scott Evangelista As CEO To Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors.

Over her distinguished tenure, Ms. Orne helped guide Trinity’s evolution from a consulting firm to a global commercial solutions provider, and played a key role in shaping the culture and developing future leaders.

A well-recognized pharmaceutical industry executive, Mr. Evangelista brings over 30 years of strategic leadership and operational expertise to Trinity, having previously served in consulting, CRO, and biotechnology senior management roles at global companies. Mr. Evangelista has served on Trinity’s Board of Advisors for the past three years, gaining a deep understanding of the organization, its people, and its clients, and playing a key role in helping management shape the vision and strategy of the company.

“Trinity is focused on becoming the leader in technology-enabled services and products that help clients and employees effectively navigate today’s unprecedented pace of change,” said Matt Jennings, Executive Chairman of Trinity and Operating Partner of Kohlberg. “Scott is a proven leader who knows how to drive transformational growth in companies while preserving and leveraging what makes them exceptional: their people, their expertise, and a deep commitment to excellence. Through his leadership on the board of advisors, he’s demonstrated that he is ideally suited to lead Trinity into its next chapter of growth.”

Mr. Evangelista brings proven leadership experience across both dynamic startups and large multinational organizations, consistently driving results and fostering collaborative, high-performing teams. He currently serves on the board of directors of Worldwide Clinical Trials, advising on growth and innovation as an Operating Executive of Kohlberg, and previously held senior executive leadership roles at IQVIA, Ironshore Pharmaceuticals, and Deloitte, as well as founding of Swiftwater Group. With his oversight as CEO, Trinity will be well positioned to further its mission to power the future of life sciences commercialization by delivering client solutions that bring together human and artificial intelligence.

“Trinity has long been recognized for its client-centric approach and expertise in driving commercialization excellence, and I am honored to join the company at this pivotal time in its journey,” added Mr. Evangelista. “I look forward to building on Trinity’s strong foundation by accelerating innovation, investing in data and technology, and advancing value for patients, clients and employees. I cannot think of an organization better suited to help life sciences companies navigate a dynamic and complex market and I am excited for what’s ahead.”

Jennings concluded: “I want to express our deep appreciation to Leslie for more than twenty years of dedicated service and enduring contributions to both Trinity and the life sciences industry. We look forward to continuing to benefit from her experience as she transitions to Senior Advisor.”

About Trinity

Trinity powers the future of life sciences commercialization through the fusion of human and artificial intelligence. By blending deep therapeutic expertise and trusted human ingenuity with a purpose-built technology platform, Trinity accelerates clarity and confidence at every step of the commercialization journey—from pre-launch to scale to loss of exclusivity. For more than 30 years, the world’s leading pharmaceutical, biotech, and medtech companies have relied on Trinity’s foresight, execution, and partnership to deliver confident product launches, decisive market advantage, and measurable patient impact. During that time, Trinity expanded from its first office in Waltham, MA to 1,300 professionals across 14 offices and five continents, setting new industry standards in quality, responsiveness, and client partnership. For more information, visit Trinity at www.trinitylifesciences.com.

Contacts

Richard Lorezen
rlorenzen@fifthavenuebrands.com